Upstream Bio (UPB) Change in Account Payables (2023 - 2026)

Upstream Bio's Change in Account Payables history runs 4 years deep, the most recent figure standing at -$1.0 million for Q1 2026.

• On a quarterly basis, Change in Account Payables fell 242.9% year-over-year to -$1.0 million in Q1 2026; TTM through Mar 2026 was -$3.0 million, a 189.98% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 163.51% from the prior year.
• Change in Account Payables advanced to -$1.0 million in Q1 2026 per UPB's latest filing, from -$1.2 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $3.7 million in Q2 2024 and bottomed at -$2.2 million in Q2 2025.
• The 4-year median for Change in Account Payables is -$394500.0 (2024), against an average of $147700.0.
• Across the five-year window, Change in Account Payables surged 905.17% in 2025 and plunged 242.9% in 2026, its largest moves.
• Year by year, Change in Account Payables stood at $1.8 million in 2023, then plunged by 149.57% to -$871000.0 in 2024, then plunged by 40.76% to -$1.2 million in 2025, then advanced by 17.13% to -$1.0 million in 2026.
• Per Business Quant, the three latest UPB Change in Account Payables figures stand at -$1.0 million (Q1 2026), -$1.2 million (Q4 2025), and $1.4 million (Q3 2025).